How to improve current therapeutic standards in upper respiratory infections: value of fusafungine

References

• Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998;9:50–5
   Google Scholar
• Kaiser L, Lew D, Hirschel B, et al. Effect of antibiotic treatment in the subset of common cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507–10
   PubMed Web of Science ®Google Scholar
• Gonzales R, Malone DC, Maselli JH, et al. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001;15:757–62
   Google Scholar
• Agence du Médicament (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Presse Med 1999 28:406–14
   Google Scholar
• Centre de Coordination de la Lutte contre les Infections Nosocomiales de l’Interrégion Paris-Nord (CCLIN Paris-Nord). Surveillance des bactéries multirésistantes à partir du laboratoire dans les hôpitaux de l’interrégion Paris-Nord (hors Assistance Publique-Hôpitaux de Paris): rapport des résultats 2001. Paris: CCLIN Paris Nord; 2002
   Google Scholar
• Witte W. Antibiotic resistance in Gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 1999;44:1–9
   PubMed Web of Science ®Google Scholar
• Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851–3
   Google Scholar
• Klugman KP, Goldstein F, Kohno S, et al. The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci. Clin Microbiol Infect 1997;3\(Suppl.1):S48–S60
   Google Scholar
• Laurans G, Murbach V, Cattier B, et al. Observatoires régionaux du pneumocoque: surveillance de la sensibilité aux antibiotiques des pneumocoques isolés en situation pathogène en France en 1999. B.E.H. No 33, 2001
   Google Scholar
• Pichichero ME. Resistant respiratory pathogens and extended-spectrum antibiotics. Am Fam Physician 1995;52:1739–46
   PubMed Web of Science ®Google Scholar
• Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001;357:1851–3
   Google Scholar
• Guillemot D. Les antibiotiques sont-ils surconsommés? Rev Prat 1998;48:585–6
   PubMedGoogle Scholar
• Ball P, Baquero F, Cars O, et al.; The Consensus Group on Resistance and Prescribing in Respiratory Tract Infection. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother 2002;49:31–40
   Google Scholar
• Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001;134:479–86
   PubMed Web of Science ®Google Scholar
• Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Ann Otolaryngol Chir Cervicofac 1999;116:302–14
   Google Scholar
• Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Rhinopharyngite aiguë. Synthèse, recommandation, argumentaire. Ann Otolaryngol Chir Cervicofac 1999;116:302–14
   Google Scholar
• AFSSaPS. Antibiothérapie par voie générale en pratique courante: angine. Recommandation. Réactualisation 2002
   Google Scholar
• Références médicales opposables. Prescription des antibiotiques en pratique courante. Infections ORL et respiratoires. Journal Officiel 14 novembre 1998
   Google Scholar
• Bradley CP. Decision making and prescribing patterns – a literature review. Fam Pract 1991;8:276–87
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Gill P. Pressure to prescribe. Br Med J 1997;315:1482–3
   PubMed Web of Science ®Google Scholar
• Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perceptions of patients’ expectations - a questionnaire study Br Med J 1997;315:520–3
   Google Scholar
• Misrahi L, Bourrillon A, Lebrun T, Dervaux B. Antibiotics for nasopharyngitis in children, in France: the gap between guidelines and daily practice. Med Mal Infect 2003;33:570–8
   Web of Science ®Google Scholar
• Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35:113–25
   PubMed Web of Science ®Google Scholar
• Gonzales R, Bartlett JG, Besser RE, Hickner JM, Hoffman JR, Dande MA. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Emerg Med 2001;37:698–702
   PubMed Web of Science ®Google Scholar
• Hickner JM, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001;134:498–505
   PubMed Web of Science ®Google Scholar
• Cooper RJ, Hoffmann JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001;134:509–17
   PubMed Web of Science ®Google Scholar
• Laccoureye O, Cauchois R, Landais P, German-Fattal M. The impact of fusafungine on the prescription of antibiotics in the treatment of rhinopharyngitis in France. Press Med 2003;32:615–9
   Google Scholar
• Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSaPS). Antibiothérapie par voie générale en pratique courante: infections ORL et respiratoires basses. Rhinopharyngite aiguë. Agence du Médicament; 1999
   Google Scholar
• Wilson R, Alton E, Rutman A, et al. Upper respiratory tract viral infection and mucociliary clearance. Eur J Respir Dis 1987;70:272–9
   PubMedGoogle Scholar
• Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Sem Pediatr Infect Dis 1998;9:50–5
   Google Scholar
• Simmons FER, Grimm PG. Histamine H1-receptors in the nasal mucosa: a mystery solved? Clin Exp Allergy 1996;26:368–70
   PubMed Web of Science ®Google Scholar
• Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993;307:982–6
   Google Scholar
• Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. Br Med J 1995;310:1125–9
   Google Scholar
• François M. Place des traitements non antibiotiques (généraux et locaux) dans la rhinopharyngite. Med Mal Infect 1997;27sp: 367–71
   Google Scholar
• Boek WM, Graamans K, Natzijl H, van Rijk PP, Huizing EH. Nasal mucociliary transport: new evidence for a key role of ciliary beat frequency. Laryngoscope 2002;112:570–3
   Google Scholar
• Sperber SJ, Sorrentino JV, Riker DK, Hayden FG. Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhino-virus colds. Bull New York Acad Med 1989;65:145–60
   PubMedGoogle Scholar
• Milgrom H, Bender B. Adverse effects of medications for rhinitis. Ann Allergy Asthma Immunol 1997;78:439–46
   PubMed Web of Science ®Google Scholar
• Gwaltney JM Jr, Druce HM. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis 1997;25:1188–94
   PubMed Web of Science ®Google Scholar
• Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT. Effectiveness and safety of intranasal ipratropium bromide in common colds: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;125:89–97
   Google Scholar
• Farr BM, Gwaltney JM Jr, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990;162:1173–7
   PubMed Web of Science ®Google Scholar
• Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM Jr. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009–14
   PubMedGoogle Scholar
• Puhakka T, Mäkela MJ, Malmström K, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol 1998;101:726–31
   PubMed Web of Science ®Google Scholar
• Ruohola A, Heikkinen T, Waris M, Puhakka T, Ruuskanen O. Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J Allergy Clin Immunol 2000;106:467–71
   Google Scholar
• Knutsson U, Stierma P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995;144:301–10
   PubMed Web of Science ®Google Scholar
• Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br J Clin Pharmacol 1995;38:521–5
   Google Scholar
• German-Fattal M. Fusafungine: an antimicrobial agent for the local treatment of respiratory tract infections. Clin Drug Invest 1996;12:308–17
   Web of Science ®Google Scholar
• German-Fattal M. Fusafungine, an antimicrobial with anti-inflammatory properties in respiratory tract infections. Clin Drug Invest 2001;21:653–70
   Web of Science ®Google Scholar
• Karam-Sarkis D, German-Fattal M, Bourlioux P. Effects of fusafungine on adherence of Haemophilus influenzae type b to human epithelial cells in vitro. Biomed Pharmacother 1991;45:301–6
   PubMed Web of Science ®Google Scholar
• Cuénant O. Value of Locabiotal® aerosol in rhinosinusitis. Rhinology 1988;(Suppl 5):69–74
   Google Scholar
• Reinert P. Value of rapid tests for the detection of streptococcal infections: illustration by a study of Locabiotal Aerosol in tonsillitis. Maladies Med/Drugs Dis 1989;5:113–23
   Google Scholar
• Samolinski B, Zawista E, Arcimowitz M, et al. Influence of fusafungine upon viral and bacterial infections. Med Sci Monit 1997;3:736–43
   Google Scholar
• Kroslak M. Efficacy and acceptability of fusafungine, a local treatment for both nose and throat infections, in adult patients with upper respiratory tract infections. Curr Med Res Opin 2002;18:194–200
   PubMed Web of Science ®Google Scholar
• Lund V, Grouin JM, Eccles R, et al. Efficacy of fusafungine in acute rhinopharyngitis: a pooled analysis. Rhinology 2004; in press
   Google Scholar
• Fagnani F, German-Fattal M. Antibiotic prescribing patterns of French GPs for upper respiratory tract infections. Am J Respir Med 2003;2:491–8
   PubMedGoogle Scholar